Readystate Asset Management LP Amgen Inc Call Options Transaction History

Readystate Asset Management LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $7.89 Million - $8.6 Million	25,500 Added 1416.67%	27,300 $8.8 Billion
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $7.07 Million - $8.59 Million	-26,900 Reduced 93.73%	1,800 $562 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $7.23 Million - $8.73 Million	26,900 Added 1494.44%	28,700 $8.16 Billion
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $127,850 - $144,230	500 Added 38.46%	1,800 $518 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $278,551 - $329,381	1,300 New	1,300 $289 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Readystate Asset Management LP with notifications on news.